This Is Not A Drill . . . FDA Publishes Fee Rates Under the Over-the-Counter Monograph Drug User Fee Program for Fiscal Year 2021 | Arnall Golden Gregory LLP

On March 26, 2021, the Food and Drug Administration (FDA) issued a new
Federal
Register notice finally announcing the fee rates under the Over-the-Counter (OTC) Monograph Drug User Fee Program for Fiscal Year 2021.
1  As we discussed in a previous Bulletin, the CARES Act, among other things, amended the Federal Food, Drug, and Cosmetic Act (FD&C Act) to allow FDA to assess and collect user fees from qualifying owners of OTC monograph drug facilities
2  and qualifying submitters of OTC monograph order requests (OMORs).
3  The fees are meant to support FDA in its OTC monograph drug activities, including inspections of facilities associated with such products.

Related Keywords

United States , ,Department Of Health ,Human Services ,Drug Administration ,Monograph Drug User Fee Program ,Fiscal Year ,Federal Food ,Cosmetic Act ,Active Pharmaceutical Ingredients ,Order Requests ,Over The Counter Monograph Drug User Fee Program ,Fee Rates ,ஒன்றுபட்டது மாநிலங்களில் ,துறை ஆஃப் ஆரோக்கியம் ,மனிதன் சேவைகள் ,நிதி ஆண்டு ,கூட்டாட்சியின் உணவு ,ஒப்பனை நாடகம் ,செயலில் மருந்து பொருட்கள் ,ஆர்டர் கோரிக்கைகளை ,கட்டணம் ரேட்ஸ் ,